← Eichor
Study identifier: NCT07343089 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Multicenter Real-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in France

Condition: Borrelia Infections  ·  Sponsor: University Hospital, Strasbourg, France

PhaseN/A
Planned participants100
Who can joinAll sexes, 1 Year to no upper limit
Healthy volunteersNo

About this study

Clinical, biological, radiological, and pharmacological description of cases of disseminated borreliosis (Borrelia burgdorferi sl. and Borrelia miyamotoi) occurring in patients who received drug treatment based on anti-CD20 monoclonal antibodies.

This description comes directly from the study's public registry record.

Talk to the study team

Pierre BOYER, MD  ·  33 3 69 55 14 69  ·  pierre.boyer@chru-strasbourg.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Laboratoire de Bactériologie - CHU de Strasbourg - FranceStrasbourg, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07343089